Hubert, a 67 year-old retired male, diagnosed with generalized myasthenia gravis positive for anti-acetylcholine receptor autoantibodies, was treated with efgartigimod for disease exacerbation.
Acknowledgement
This case study was provided by Prof. Olivier Boyer (M.D., Ph.D., Head of the Department of Immunology, Rouen University Hospital, France) and Dr. Henri Gondé (Pharm.D., Ph.D., Associate Professor of Pharmaceutical Technology) of the Faculty of Medicine and Pharmacy of Rouen, Normandy University, France. The authors would like to thank Dr Marie-Agnès Dragon-Durey (M.D., Ph.D., Department of Immunology, Georges Pompidou University Hospital, AP-HP, France), Prof. Jan De Bleecker (M.D., Ph.D., Department of Neurology, Ghent University Hospital, Belgium) and Dr. Joost Raaphorst (M.D., Ph.D., Department of Neurology, Amsterdam University Medical Center, Netherlands) for their critical reading of this case study.
